A novel EyePhone© App for improving adherence to glaucoma therapy
Purpose Despite advances in glaucoma treatment options, patient adherence and compliance remain very low. The EyePhone© App is a free non-commercial reminder application designed specifically for the needs of glaucoma patients. In this study, we evaluated its usefulness in improving adherence to med...
Gespeichert in:
| Veröffentlicht in: | Graefe's archive for clinical and experimental ophthalmology Jg. 259; H. 5; S. 1253 - 1262 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
Berlin/Heidelberg
Springer Berlin Heidelberg
01.05.2021
Springer Nature B.V |
| Schlagworte: | |
| ISSN: | 0721-832X, 1435-702X, 1435-702X |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | Purpose
Despite advances in glaucoma treatment options, patient adherence and compliance remain very low. The EyePhone© App is a free non-commercial reminder application designed specifically for the needs of glaucoma patients. In this study, we evaluated its usefulness in improving adherence to medical treatment among glaucoma patients.
Methods
This is a prospective multicenter interventional study. Glaucoma patients were recruited from a tertiary center and a large community glaucoma service center. After a short explanation, the EyePhone© App was installed on their smartphone device, and the notifications for the current medical treatment were entered. After enrollment and at 1-month follow-up, subjects completed the Morisky Medication Adherence Scale (MMAS-8) and the Quality of Life and Glaucoma 17-item (GlauQOL-17) questionnaires for evaluation of adherence and QOL, respectively.
Results
In the study, 133 patients (71 men and 62 women) aged 62±15.5 years and using 2.0±0.9 IOP-lowering drugs participated. The proportion of highly adherent subjects improved from 29.3% (39/133) at baseline to 42.1% (56/133) at follow-up (
P
< 0.001), and the proportion of poorly adherent subjects decreased from 29.3 (39/133) to 20.3% (27/133) at follow-up (
P
= 0.012). QOL also improved, as evidenced by a significant increase in the GlauQOL-17 score (
P
< 0.05). In a subgroup of patients for whom IOP measurements were available, IOP reduced by 0.92 mmHg (
P
= 0.069).
Conclusions
Significant improvements in glaucoma adherence and QOL were achieved among poorly adherent glaucoma patients after 1 month of using the EyePhone© App. |
|---|---|
| AbstractList | Despite advances in glaucoma treatment options, patient adherence and compliance remain very low. The EyePhone© App is a free non-commercial reminder application designed specifically for the needs of glaucoma patients. In this study, we evaluated its usefulness in improving adherence to medical treatment among glaucoma patients.PURPOSEDespite advances in glaucoma treatment options, patient adherence and compliance remain very low. The EyePhone© App is a free non-commercial reminder application designed specifically for the needs of glaucoma patients. In this study, we evaluated its usefulness in improving adherence to medical treatment among glaucoma patients.This is a prospective multicenter interventional study. Glaucoma patients were recruited from a tertiary center and a large community glaucoma service center. After a short explanation, the EyePhone© App was installed on their smartphone device, and the notifications for the current medical treatment were entered. After enrollment and at 1-month follow-up, subjects completed the Morisky Medication Adherence Scale (MMAS-8) and the Quality of Life and Glaucoma 17-item (GlauQOL-17) questionnaires for evaluation of adherence and QOL, respectively.METHODSThis is a prospective multicenter interventional study. Glaucoma patients were recruited from a tertiary center and a large community glaucoma service center. After a short explanation, the EyePhone© App was installed on their smartphone device, and the notifications for the current medical treatment were entered. After enrollment and at 1-month follow-up, subjects completed the Morisky Medication Adherence Scale (MMAS-8) and the Quality of Life and Glaucoma 17-item (GlauQOL-17) questionnaires for evaluation of adherence and QOL, respectively.In the study, 133 patients (71 men and 62 women) aged 62±15.5 years and using 2.0±0.9 IOP-lowering drugs participated. The proportion of highly adherent subjects improved from 29.3% (39/133) at baseline to 42.1% (56/133) at follow-up (P < 0.001), and the proportion of poorly adherent subjects decreased from 29.3 (39/133) to 20.3% (27/133) at follow-up (P = 0.012). QOL also improved, as evidenced by a significant increase in the GlauQOL-17 score (P < 0.05). In a subgroup of patients for whom IOP measurements were available, IOP reduced by 0.92 mmHg (P = 0.069).RESULTSIn the study, 133 patients (71 men and 62 women) aged 62±15.5 years and using 2.0±0.9 IOP-lowering drugs participated. The proportion of highly adherent subjects improved from 29.3% (39/133) at baseline to 42.1% (56/133) at follow-up (P < 0.001), and the proportion of poorly adherent subjects decreased from 29.3 (39/133) to 20.3% (27/133) at follow-up (P = 0.012). QOL also improved, as evidenced by a significant increase in the GlauQOL-17 score (P < 0.05). In a subgroup of patients for whom IOP measurements were available, IOP reduced by 0.92 mmHg (P = 0.069).Significant improvements in glaucoma adherence and QOL were achieved among poorly adherent glaucoma patients after 1 month of using the EyePhone© App.CONCLUSIONSSignificant improvements in glaucoma adherence and QOL were achieved among poorly adherent glaucoma patients after 1 month of using the EyePhone© App. PurposeDespite advances in glaucoma treatment options, patient adherence and compliance remain very low. The EyePhone© App is a free non-commercial reminder application designed specifically for the needs of glaucoma patients. In this study, we evaluated its usefulness in improving adherence to medical treatment among glaucoma patients.MethodsThis is a prospective multicenter interventional study. Glaucoma patients were recruited from a tertiary center and a large community glaucoma service center. After a short explanation, the EyePhone© App was installed on their smartphone device, and the notifications for the current medical treatment were entered. After enrollment and at 1-month follow-up, subjects completed the Morisky Medication Adherence Scale (MMAS-8) and the Quality of Life and Glaucoma 17-item (GlauQOL-17) questionnaires for evaluation of adherence and QOL, respectively.ResultsIn the study, 133 patients (71 men and 62 women) aged 62±15.5 years and using 2.0±0.9 IOP-lowering drugs participated. The proportion of highly adherent subjects improved from 29.3% (39/133) at baseline to 42.1% (56/133) at follow-up (P < 0.001), and the proportion of poorly adherent subjects decreased from 29.3 (39/133) to 20.3% (27/133) at follow-up (P = 0.012). QOL also improved, as evidenced by a significant increase in the GlauQOL-17 score (P < 0.05). In a subgroup of patients for whom IOP measurements were available, IOP reduced by 0.92 mmHg (P = 0.069).ConclusionsSignificant improvements in glaucoma adherence and QOL were achieved among poorly adherent glaucoma patients after 1 month of using the EyePhone© App. Despite advances in glaucoma treatment options, patient adherence and compliance remain very low. The EyePhone© App is a free non-commercial reminder application designed specifically for the needs of glaucoma patients. In this study, we evaluated its usefulness in improving adherence to medical treatment among glaucoma patients. This is a prospective multicenter interventional study. Glaucoma patients were recruited from a tertiary center and a large community glaucoma service center. After a short explanation, the EyePhone© App was installed on their smartphone device, and the notifications for the current medical treatment were entered. After enrollment and at 1-month follow-up, subjects completed the Morisky Medication Adherence Scale (MMAS-8) and the Quality of Life and Glaucoma 17-item (GlauQOL-17) questionnaires for evaluation of adherence and QOL, respectively. In the study, 133 patients (71 men and 62 women) aged 62±15.5 years and using 2.0±0.9 IOP-lowering drugs participated. The proportion of highly adherent subjects improved from 29.3% (39/133) at baseline to 42.1% (56/133) at follow-up (P < 0.001), and the proportion of poorly adherent subjects decreased from 29.3 (39/133) to 20.3% (27/133) at follow-up (P = 0.012). QOL also improved, as evidenced by a significant increase in the GlauQOL-17 score (P < 0.05). In a subgroup of patients for whom IOP measurements were available, IOP reduced by 0.92 mmHg (P = 0.069). Significant improvements in glaucoma adherence and QOL were achieved among poorly adherent glaucoma patients after 1 month of using the EyePhone© App. Purpose Despite advances in glaucoma treatment options, patient adherence and compliance remain very low. The EyePhone© App is a free non-commercial reminder application designed specifically for the needs of glaucoma patients. In this study, we evaluated its usefulness in improving adherence to medical treatment among glaucoma patients. Methods This is a prospective multicenter interventional study. Glaucoma patients were recruited from a tertiary center and a large community glaucoma service center. After a short explanation, the EyePhone© App was installed on their smartphone device, and the notifications for the current medical treatment were entered. After enrollment and at 1-month follow-up, subjects completed the Morisky Medication Adherence Scale (MMAS-8) and the Quality of Life and Glaucoma 17-item (GlauQOL-17) questionnaires for evaluation of adherence and QOL, respectively. Results In the study, 133 patients (71 men and 62 women) aged 62±15.5 years and using 2.0±0.9 IOP-lowering drugs participated. The proportion of highly adherent subjects improved from 29.3% (39/133) at baseline to 42.1% (56/133) at follow-up ( P < 0.001), and the proportion of poorly adherent subjects decreased from 29.3 (39/133) to 20.3% (27/133) at follow-up ( P = 0.012). QOL also improved, as evidenced by a significant increase in the GlauQOL-17 score ( P < 0.05). In a subgroup of patients for whom IOP measurements were available, IOP reduced by 0.92 mmHg ( P = 0.069). Conclusions Significant improvements in glaucoma adherence and QOL were achieved among poorly adherent glaucoma patients after 1 month of using the EyePhone© App. |
| Author | Eliasi, Elior Jaber, Wasim Kapelushnik, Noa Skaat, Alon Singer, Reut Leshno, Ari Gaton, Dan Stern, Ori Madgar, Shiran Vorobichik-Berar, Ofri |
| Author_xml | – sequence: 1 givenname: Ari orcidid: 0000-0002-8717-1659 surname: Leshno fullname: Leshno, Ari email: arileshno@gmail.com organization: The Sam Rothberg Glaucoma Center, Goldschleger Eye Institute, Sheba Medical Center, Sackler Faculty of Medicine, Tel Aviv University – sequence: 2 givenname: Dan surname: Gaton fullname: Gaton, Dan organization: Sackler Faculty of Medicine, Tel Aviv University, Department of Ophthalmology, Rabin Medical Center, Glaucoma Institute, “Clalit” Healthcare Services, Century Tower – sequence: 3 givenname: Reut surname: Singer fullname: Singer, Reut organization: The Sam Rothberg Glaucoma Center, Goldschleger Eye Institute, Sheba Medical Center, Sackler Faculty of Medicine, Tel Aviv University – sequence: 4 givenname: Elior surname: Eliasi fullname: Eliasi, Elior organization: Sackler Faculty of Medicine, Tel Aviv University – sequence: 5 givenname: Ofri surname: Vorobichik-Berar fullname: Vorobichik-Berar, Ofri organization: The Sam Rothberg Glaucoma Center, Goldschleger Eye Institute, Sheba Medical Center – sequence: 6 givenname: Shiran surname: Madgar fullname: Madgar, Shiran organization: The Sam Rothberg Glaucoma Center, Goldschleger Eye Institute, Sheba Medical Center – sequence: 7 givenname: Ori surname: Stern fullname: Stern, Ori organization: The Sam Rothberg Glaucoma Center, Goldschleger Eye Institute, Sheba Medical Center, Sackler Faculty of Medicine, Tel Aviv University – sequence: 8 givenname: Wasim surname: Jaber fullname: Jaber, Wasim organization: The Sam Rothberg Glaucoma Center, Goldschleger Eye Institute, Sheba Medical Center, Sackler Faculty of Medicine, Tel Aviv University – sequence: 9 givenname: Noa surname: Kapelushnik fullname: Kapelushnik, Noa organization: The Sam Rothberg Glaucoma Center, Goldschleger Eye Institute, Sheba Medical Center, Sackler Faculty of Medicine, Tel Aviv University – sequence: 10 givenname: Alon surname: Skaat fullname: Skaat, Alon organization: The Sam Rothberg Glaucoma Center, Goldschleger Eye Institute, Sheba Medical Center, Sackler Faculty of Medicine, Tel Aviv University |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33528649$$D View this record in MEDLINE/PubMed |
| BookMark | eNpdkctKAzEYhYNU7EVfwIUE3LgZzWWSmSxrqRcQdKHQXUgzSTtlJhknM4U-kq_hkxltRXD1w38-DodzxmDgvDMAnGN0jRHKbgJCKc4SRHCCGBI44UdghFPKkgyRxQCMUBalnJLFEIxD2KDIU4ZPwJBSRnKeihG4nULnt6aC8515WUf_zw84bRpofQvLumn9tnQrqIq1aY3TBnYerirVa18r2MWnanan4NiqKpizw52At7v56-wheXq-f5xNn5KGYNolhREaW8FzqwTXWJFUKyEsQgXOrKUpw4JwvtQiV1xphGwmcqo1j8SSmVTRCbja-8ZU770JnazLoE1VKWd8HyRJc8ZwFquI6OU_dOP71sV0kjBCWGwPs0hdHKh-WZtCNm1Zq3Ynf9uJAN0DIUpuZdo_G4zk9wZyv4GMG8ifDSSnX_MyeBY |
| Cites_doi | 10.1111/j.1600-0420.2007.00999.x 10.1016/j.ophtha.2011.05.013 10.5301/EJO.2010.6112 10.1016/j.ophtha.2014.05.013 10.1016/j.ajo.2009.08.011 10.1089/10807680260362687 10.1016/j.ophtha.2019.10.022 10.1016/S0149-2918(00)88274-0 10.1016/bs.pbr.2015.04.007 10.1089/jop.2005.21.483 10.1007/s10792-008-9278-3 10.1136/heartjnl-2018-313479 10.2147/PPA.S23780 10.1016/j.ophtha.2015.03.026 10.1097/IJG.0000000000000431 10.1016/S0149-2918(96)80042-7 10.1001/archophthalmol.2009.96 10.1016/j.ophtha.2005.07.016 10.1146/annurev-pharmtox-011711-113247 10.1016/j.ophtha.2019.09.041 10.1016/S0002-9394(14)71282-6 10.1136/bjo.80.5.389 10.1016/j.ophtha.2004.12.035 10.1590/S0004-27492012000400004 10.1001/archophthalmol.2012.1607 10.1097/00061198-199910000-00008 10.1097/IJG.0000000000000150 10.1038/eye.2011.269 10.1016/S0161-6420(97)30314-5 10.1097/IJG.0b013e3181f3eb4a 10.1111/bjd.16667 10.1038/clpt.2014.59 10.1001/archopht.121.1.48 10.1016/j.ajo.2011.08.035 10.1097/IJG.0000000000000504 |
| ContentType | Journal Article |
| Copyright | The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature 2021 The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature 2021. |
| Copyright_xml | – notice: The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature 2021 – notice: The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature 2021. |
| DBID | NPM 3V. 7TK 7X7 7XB 88E 8AO 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 |
| DOI | 10.1007/s00417-021-05091-6 |
| DatabaseName | PubMed ProQuest Central (Corporate) Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central ProQuest One Community College ProQuest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database Proquest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic |
| DatabaseTitle | PubMed ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic ProQuest One Academic Middle East (New) PubMed |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1435-702X |
| EndPage | 1262 |
| ExternalDocumentID | 33528649 10_1007_s00417_021_05091_6 |
| Genre | Journal Article |
| GroupedDBID | --- -53 -5E -5G -BR -EM -Y2 -~C .55 .86 .VR 06C 06D 0R~ 0VY 199 1N0 2.D 203 28- 29I 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 3O- 3V. 4.4 406 408 409 40D 40E 53G 5QI 5VS 67Z 6NX 78A 7X7 88E 8AO 8FI 8FJ 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABLJU ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACAOD ACBXY ACDTI ACGFS ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACUDM ACZOJ ADBBV ADHIR ADINQ ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFEXP AFKRA AFLOW AFQWF AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AOCGG ARMRJ AXYYD AZFZN B-. BA0 BBWZM BDATZ BENPR BGNMA BPHCQ BSONS BVXVI CAG CCPQU COF CSCUP DDRTE DL5 DNIVK DPUIP EBD EBLON EBS EIOEI EJD EMOBN EN4 ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GRRUI GXS H13 HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ IMOTQ ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH LAS LLZTM M1P M4Y MA- N2Q N9A NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM P19 P2P P9S PF0 PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R89 R9I RHV RIG RNI ROL RPX RRX RSV RZK S16 S1Z S26 S27 S28 S37 S3B SAP SCLPG SDE SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 X7M YLTOR Z45 Z7U Z81 Z82 Z83 Z87 Z8O Z8U Z8V Z8W Z91 ZMTXR ZOVNA ~EX AAPKM ABBRH ABDBE ABFSG ABRTQ ACSTC ADHKG AEZWR AFDZB AFHIU AFOHR AGQPQ AHPBZ AHWEU AIXLP ATHPR AYFIA NPM PHGZM PHGZT PJZUB PPXIY 7TK 7XB 8FK K9. PKEHL PQEST PQUKI PRINS 7X8 PUEGO |
| ID | FETCH-LOGICAL-p213t-de9c1f968fa96c1a24ca99f00d17ff34519266bc98a6ac00f7983cc6f00b5e4a3 |
| IEDL.DBID | RSV |
| ISICitedReferencesCount | 8 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000613999100008&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0721-832X 1435-702X |
| IngestDate | Fri Sep 05 06:47:16 EDT 2025 Wed Nov 05 01:38:53 EST 2025 Mon Jul 21 05:56:01 EDT 2025 Fri Feb 21 02:48:34 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5 |
| Keywords | Glaucoma Adherence Smartphone Application Quality of life |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-p213t-de9c1f968fa96c1a24ca99f00d17ff34519266bc98a6ac00f7983cc6f00b5e4a3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0002-8717-1659 |
| PMID | 33528649 |
| PQID | 2522500715 |
| PQPubID | 48614 |
| PageCount | 10 |
| ParticipantIDs | proquest_miscellaneous_2485517050 proquest_journals_2522500715 pubmed_primary_33528649 springer_journals_10_1007_s00417_021_05091_6 |
| PublicationCentury | 2000 |
| PublicationDate | 20210500 2021-May 20210501 |
| PublicationDateYYYYMMDD | 2021-05-01 |
| PublicationDate_xml | – month: 5 year: 2021 text: 20210500 |
| PublicationDecade | 2020 |
| PublicationPlace | Berlin/Heidelberg |
| PublicationPlace_xml | – name: Berlin/Heidelberg – name: Germany – name: Heidelberg |
| PublicationSubtitle | Incorporating German Journal of Ophthalmology |
| PublicationTitle | Graefe's archive for clinical and experimental ophthalmology |
| PublicationTitleAbbrev | Graefes Arch Clin Exp Ophthalmol |
| PublicationTitleAlternate | Graefes Arch Clin Exp Ophthalmol |
| PublicationYear | 2021 |
| Publisher | Springer Berlin Heidelberg Springer Nature B.V |
| Publisher_xml | – name: Springer Berlin Heidelberg – name: Springer Nature B.V |
| References | Blumberg, Skaat, Liebmann (CR3) 2015; 221 Guerin, Flynn, Brady, O’Brien (CR25) 2009; 29 Reardon, Kotak, Schwartz (CR9) 2011; 5 Sleath, Blalock, Covert (CR13) 2011; 118 CR19 Patel, Spaeth (CR26) 1995; 26 Taylor, Galbraith, Mills (CR27) 2002; 18 Saeedi, Luzuriaga, Ellish, Robin (CR41) 2015; 24 CR17 Tham, Li, Wong (CR2) 2014; 121 Leske, Heijl, Hussein (CR10) 2003; 121 Quigley (CR1) 1996; 80 Pastor, Harbin (CR30) 2013; 110 Santo, Singleton, Rogers (CR18) 2019; 105 Olthoff, Schouten, Van De Borne, Webers (CR8) 2005; 112 Newman-Casey, Robin, Blachley (CR16) 2015; 122 CR31 Killeen, Mackenzie, Heisler (CR20) 2016; 25 Vrijens, Urquhart (CR44) 2014; 95 Mansberger (CR6) 2010; 149 Barber, Strahlman, Laibovitz (CR39) 1997; 104 Laibovitz, Boyle, Snyder (CR36) 1996; 18 Newman-Casey, Niziol, Gillespie (CR15) 2020; 127 Hermann, Bron, Creuzot-Garcher, Diestelhorst (CR32) 2011; 20 Schenker, Maloney, Liss (CR37) 1999; 21 Svendsen, Andersen, Andersen (CR40) 2018; 179 Waisbourd, Dhami, Zhou (CR29) 2016; 25 Paula, Furtado, Santos (CR14) 2012; 75 Newman-Casey, Salman, Lee, Gatwood (CR4) 2020; 127 Skaat, Chetrit, Belkin (CR24) 2012; 153 Sverrisson, Gross, Pearson (CR38) 1999; 8 Rossi, Pasinetti, Scudeller (CR12) 2011; 21 CR5 Stewart, Chorak, Hunt, Sethuraman (CR11) 1993; 116 Gray, Fenerty, Harper (CR33) 2012; 26 Blaschke, Osterberg, Vrijens, Urquhart (CR7) 2012; 52 CR28 CR22 CR21 Stone, Robin, Novack (CR43) 2009; 127 CR42 Covert, Robin, Novack (CR45) 2005; 112 Sakai, Shinjyo, Nakamura (CR35) 2005; 21 Glanz, Beck, Bundy (CR34) 2012; 130 Béchetoille, Arnould, Bron (CR23) 2008; 86 |
| References_xml | – ident: CR22 – volume: 86 start-page: 71 year: 2008 end-page: 80 ident: CR23 article-title: Measurement of health-related quality of life with glaucoma: validation of the Glau-QoL © 36-item questionnaire publication-title: Acta Ophthalmol doi: 10.1111/j.1600-0420.2007.00999.x – volume: 118 start-page: 2398 year: 2011 end-page: 2402 ident: CR13 article-title: The relationship between glaucoma medication adherence, eye drop technique, and visual field defect severity publication-title: Ophthalmology doi: 10.1016/j.ophtha.2011.05.013 – volume: 21 start-page: 410 year: 2011 end-page: 414 ident: CR12 article-title: Do adherence rates and glaucomatous visual field progression correlate? publication-title: Eur J Ophthalmol doi: 10.5301/EJO.2010.6112 – volume: 121 start-page: 2081 year: 2014 end-page: 2090 ident: CR2 article-title: Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis publication-title: Ophthalmology doi: 10.1016/j.ophtha.2014.05.013 – volume: 149 start-page: 1 year: 2010 end-page: 3 ident: CR6 article-title: Are you compliant with addressing glaucoma adherence? publication-title: Am J Ophthalmol doi: 10.1016/j.ajo.2009.08.011 – volume: 18 start-page: 401 year: 2002 end-page: 409 ident: CR27 article-title: Causes of non-compliance with drug regimens in glaucoma patients: a qualitative study publication-title: J Ocul Pharmacol Ther doi: 10.1089/10807680260362687 – volume: 127 start-page: 477 year: 2020 end-page: 483 ident: CR15 article-title: The association between medication adherence and visual field progression in the collaborative initial glaucoma treatment study publication-title: Ophthalmology doi: 10.1016/j.ophtha.2019.10.022 – volume: 21 start-page: 138 year: 1999 end-page: 147 ident: CR37 article-title: Patient preference, efficacy, and compliance with timolol maleate ophthalmic gel-forming solution versus timolol maleate ophthalmic solution in patients with ocular hypertension or open-angle glaucoma publication-title: Clin Ther doi: 10.1016/S0149-2918(00)88274-0 – volume: 221 start-page: 81 year: 2015 end-page: 101 ident: CR3 article-title: Emerging risk factors for glaucoma onset and progression publication-title: Prog Brain Res doi: 10.1016/bs.pbr.2015.04.007 – volume: 110 start-page: 52 year: 2013 ident: CR30 article-title: Improving compliance with eye drop medications publication-title: Mo Med – volume: 21 start-page: 483 year: 2005 end-page: 489 ident: CR35 article-title: Comparison of latanoprost monotherapy and combined therapy of 0.5% timolol and 1% dorzolamide in chronic primary angle-closure glaucoma (CACG) in Japanese patients publication-title: J Ocul Pharmacol Ther doi: 10.1089/jop.2005.21.483 – volume: 29 start-page: 511 year: 2009 end-page: 516 ident: CR25 article-title: Worldwide geographical distribution of ophthalmology publications publication-title: Int Ophthalmol doi: 10.1007/s10792-008-9278-3 – volume: 105 start-page: 323 year: 2019 end-page: 329 ident: CR18 article-title: Medication reminder applications to improve adherence in coronary heart disease: a randomised clinical trial publication-title: Heart doi: 10.1136/heartjnl-2018-313479 – volume: 5 start-page: 441 year: 2011 end-page: 463 ident: CR9 article-title: Objective assessment of compliance and persistence among patients treated for glaucoma and ocular hypertension: a systematic review publication-title: Patient Prefer Adherence doi: 10.2147/PPA.S23780 – volume: 122 start-page: 1308 year: 2015 end-page: 1316 ident: CR16 article-title: The most common barriers to glaucoma medication adherence: a cross-sectional survey publication-title: Ophthalmology doi: 10.1016/j.ophtha.2015.03.026 – volume: 25 start-page: 815 year: 2016 end-page: 821 ident: CR20 article-title: User-centered design of the eyeGuide: a tailored glaucoma behavior change program publication-title: J Glaucoma doi: 10.1097/IJG.0000000000000431 – volume: 18 start-page: 821 year: 1996 end-page: 832 ident: CR36 article-title: Dorzolamide versus pilocarpine as adjunctive therapies to timolol: a comparison of patient preference and impact on daily life publication-title: Clin Ther doi: 10.1016/S0149-2918(96)80042-7 – ident: CR42 – volume: 127 start-page: 732 year: 2009 end-page: 736 ident: CR43 article-title: An objective evaluation of eyedrop instillation in patients with glaucoma publication-title: Arch Ophthalmol doi: 10.1001/archophthalmol.2009.96 – volume: 112 start-page: 1849.e1 year: 2005 end-page: 1849.e2 ident: CR45 article-title: Systemic medications and glaucoma patients publication-title: Ophthalmology doi: 10.1016/j.ophtha.2005.07.016 – ident: CR21 – volume: 52 start-page: 275 year: 2012 end-page: 301 ident: CR7 article-title: Adherence to medications: Insights arising from studies on the unreliable link between prescribed and actual drug dosing histories publication-title: Annu Rev Pharmacol Toxicol doi: 10.1146/annurev-pharmtox-011711-113247 – ident: CR19 – volume: 127 start-page: 589 year: 2020 end-page: 598 ident: CR4 article-title: Cost-utility analysis of glaucoma medication adherence publication-title: Ophthalmology doi: 10.1016/j.ophtha.2019.09.041 – volume: 116 start-page: 176 year: 1993 end-page: 181 ident: CR11 article-title: Factors associated with visual loss in patients with advanced glaucomatous changes in the optic nerve head publication-title: Am J Ophthalmol doi: 10.1016/S0002-9394(14)71282-6 – volume: 80 start-page: 389 year: 1996 end-page: 393 ident: CR1 article-title: The number of people with glaucoma worldwide in 2010 and 2020 publication-title: Br J Ophthalmol doi: 10.1136/bjo.80.5.389 – volume: 112 start-page: 953 year: 2005 end-page: 961.e7 ident: CR8 article-title: Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension: an evidence-based review publication-title: Ophthalmology doi: 10.1016/j.ophtha.2004.12.035 – volume: 75 start-page: 243 year: 2012 end-page: 246 ident: CR14 article-title: Risk factors for blindness in patients with open-angle glaucoma followed-up for at least 15 years publication-title: Arq Bras Oftalmol doi: 10.1590/S0004-27492012000400004 – volume: 130 start-page: 1252 year: 2012 end-page: 1258 ident: CR34 article-title: Impact of a health communication intervention to improve glaucoma treatment adherence: results of the interactive study to increase glaucoma adherence to treatment trial publication-title: Arch Ophthalmol doi: 10.1001/archophthalmol.2012.1607 – volume: 26 start-page: 233 year: 1995 end-page: 236 ident: CR26 article-title: Compliance in patients prescribed eyedrops for glaucoma publication-title: Ophthalmic Surg – volume: 8 start-page: 315 year: 1999 end-page: 324 ident: CR38 article-title: The dorzolamide/timolol combination versus timolol plus pilocarpine: patient preference and impact on daily life publication-title: J Glaucoma doi: 10.1097/00061198-199910000-00008 – volume: 24 start-page: e95 year: 2015 end-page: e102 ident: CR41 article-title: Potential limitations of e-mail and text messaging in improving adherence in glaucoma and ocular hypertension publication-title: J Glaucoma doi: 10.1097/IJG.0000000000000150 – volume: 26 start-page: 407 year: 2012 end-page: 417 ident: CR33 article-title: Individualised patient care as an adjunct to standard care for promoting adherence to ocular hypotensive therapy: an exploratory randomised controlled trial publication-title: Eye doi: 10.1038/eye.2011.269 – ident: CR17 – volume: 104 start-page: 334 year: 1997 end-page: 342 ident: CR39 article-title: Validation of a questionnaire for comparing the tolerability of ophthalmic medications publication-title: Ophthalmology doi: 10.1016/S0161-6420(97)30314-5 – ident: CR31 – volume: 20 start-page: 502 year: 2011 end-page: 508 ident: CR32 article-title: Measurement of adherence to brimonidine therapy for glaucoma using electronic monitoring publication-title: J Glaucoma doi: 10.1097/IJG.0b013e3181f3eb4a – volume: 179 start-page: 1062 year: 2018 end-page: 1071 ident: CR40 article-title: A smartphone application supporting patients with psoriasis improves adherence to topical treatment: a randomized controlled trial publication-title: Br J Dermatol doi: 10.1111/bjd.16667 – volume: 95 start-page: 617 year: 2014 end-page: 626 ident: CR44 article-title: Methods for measuring, enhancing, and accounting for medication adherence in clinical trials publication-title: Clin Pharmacol Ther doi: 10.1038/clpt.2014.59 – volume: 121 start-page: 48 year: 2003 end-page: 56 ident: CR10 article-title: Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial publication-title: Arch Ophthalmol doi: 10.1001/archopht.121.1.48 – ident: CR5 – volume: 153 start-page: 214 year: 2012 end-page: 221.e1 ident: CR24 article-title: Time trends in the incidence and causes of blindness in Israel publication-title: Am J Ophthalmol doi: 10.1016/j.ajo.2011.08.035 – ident: CR28 – volume: 25 start-page: e787 year: 2016 end-page: e791 ident: CR29 article-title: The Wills eye glaucoma app: Interest of patients and their caregivers in a smartphone-based and tablet-based glaucoma application publication-title: J Glaucoma doi: 10.1097/IJG.0000000000000504 |
| SSID | ssj0004351 |
| Score | 2.3530242 |
| Snippet | Purpose
Despite advances in glaucoma treatment options, patient adherence and compliance remain very low. The EyePhone© App is a free non-commercial reminder... Despite advances in glaucoma treatment options, patient adherence and compliance remain very low. The EyePhone© App is a free non-commercial reminder... PurposeDespite advances in glaucoma treatment options, patient adherence and compliance remain very low. The EyePhone© App is a free non-commercial reminder... |
| SourceID | proquest pubmed springer |
| SourceType | Aggregation Database Index Database Publisher |
| StartPage | 1253 |
| SubjectTerms | Eye Glaucoma Medical treatment Medicine Medicine & Public Health Ophthalmology Patients Quality of life |
| SummonAdditionalLinks | – databaseName: ProQuest Central dbid: BENPR link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8NAEB60FfHi-xGtsoJHF5NsXnuSKi1eLEUUegubzYYWJKltWuhP8m_4y5xNtu1B8eI5QzLszO58mdn5BuCGSXQcR3nUVQH-oCShoCKQDmWuz7KIKRYkSTVsIuz1osGA903CbWquVS7PxOqgTgupc-R3LgIFXwdE_378QfXUKF1dNSM0NqGpmcq8BjQfOr3-y7ozklUDGDUJGEXfHZi2map5TlNNhVRfUdAcKA4NfgOZPwqkVdzp7v1X433YNYiTtGsXOYANlR_C9rOpqR_BQ5vkxVy9k85C9YdFrr4-CWJTgmiWjJYpByLSYd0YSMqCIOSeoQ6C1N1bi2N463ZeH5-omaxAx67DSpoqLp2MB1EmOFpGuJ4UnGe2nTphljFNOYOBO5E8EoGQtp2FPGJSBiiR-MoT7AQaOSp0BgTxQSo9FNXARfosQYTFXRFWVIaZUBa0lqsTm-0xjddLY8H16jE6tq5WiFwVM5TRtDWa7Me24LQ2RjyuGThi3SgW4XcsuF1aZ_3yFRFzZeAYDRxXBo6D8791uYAdt3YHajstaJSTmbqELTkvR9PJlXGtbyVY1Ck priority: 102 providerName: ProQuest |
| Title | A novel EyePhone© App for improving adherence to glaucoma therapy |
| URI | https://link.springer.com/article/10.1007/s00417-021-05091-6 https://www.ncbi.nlm.nih.gov/pubmed/33528649 https://www.proquest.com/docview/2522500715 https://www.proquest.com/docview/2485517050 |
| Volume | 259 |
| WOSCitedRecordID | wos000613999100008&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAVX databaseName: SpringerLINK Contemporary 1997-Present customDbUrl: eissn: 1435-702X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0004351 issn: 0721-832X databaseCode: RSV dateStart: 19970101 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba8IwFD5MHWMvu1_cnGSwxwXaprc86lD2MhF3wbeSxhSFUUWr4E_a39gv20na6sN82V5KoYcknJw0X3vyfQfggUkMHFu51FE-fqDEgaDClzZljseSkCnmx7EpNhH0euFwyPsFKWxRnnYvU5LmTb0hu2lpqIDqIwVas8SmfgVqeBPq5Th4_diyIZkpuqiFvyjG67CgyuxuYxew_JUUNXtN9_h_ozyBowJbklYeDKewp9IzOHgpsufn0G6RdLpSn6SzVv3xNFXfXwRRKEHcSiblzwUiRuOcAkiyKUFwvcSOBcl5WusLeO923p6eaVFDgc4cm2V0pLi0E-6HieA4B8JxpeA8sayRHSQJ0-IyuEXHkofCF9KykoCHTEofLWJPuYJdQjXFAV0DQSQwki6aaogiPRYjluKOCIxoYSJUHRqlK6NiISwiB_Gdp3GMV4f7zWMMYZ2XEKmaLtFGC9RoWR-rDlf5FESzXGsj0pSwEPupw2Pp723jG8ll4_QInR4Zp0f-zd_Mb-HQyaeMWnYDqtl8qe5gX66yyWLehEowDMw1bEKt3en1B00Tcj8ogcxN |
| linkProvider | Springer Nature |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3JTuQwEC2xjIALy7A1q0cablgkdieODwixCgS0ODBS3zKO46iRUNLQ3aD-JC58BF9G2Unow6C5ceAcK7FTr-xnu-oVwG-uETi-aVJmQtygJEJRFWqfchbwLOKGh0niik2IVitqt-XNGLzWuTA2rLKeE91EnRbanpHvMSQKgV0Qg4PuA7VVo-ztal1Co4TFpRk-45att39xgvbdYezs9Pb4nFZVBWiX-bxPUyO1n8kwypTEXinW1ErKzPNSX2QZt3IruGglWkYqVNrzMiEjrnWILZLANBXH947DJM7jwoaQibYY5WFyV-7RSo5R9JR2laTjUvWssJWgNiDCKq74NPyM0v5zHetWubO57_Z_5mG24tPksHSABRgz-U-Yuq4iBhbh6JDkxZO5J6dDc9MpcvP2QpB5E-Tq5K4-UCEq7ZRpj6RfENxQDHDMipS5acMl-PMlI1iGiRw7tAoE2U-qm9jU0jId8AT5o2RKOKHGTJkGbNTWiCvn78UjUzTg18djdFt7F6NyUwywjRXlsVJGXgNWSuPH3VJfJLZpcBF-pwG7NRpGL_-QmXaAihFQsQNUHK79vy_bMH1-e30VX120LtdhhpVQpJ6_ARP9x4HZhB_6qX_Xe9xyoCbw96tR8g5oJjDR |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3LbhMxFL0KKarYUKAUAikYCXa1OmPPywtUpU2iRmmjCFEpu6nHYyuR0ExokqJ8Er_Aki_jeh7JAsQui67HmrHHx_axfc-5AB-5QuC42qNMB7hBSUJJZaBcypnPTcQ1D5KkSDYRjkbRZCLGDfhVa2FsWGU9JxYTdZore0Z-ypAo-HZB9E9NFRYx7vbP5t-pzSBlb1rrdBolRIZ6_QO3b4vPgy729SfG-r2vF5e0yjBA58zlS5pqoVwjgshIgTWUzFNSCOM4qRsaw631Ci5giRKRDKRyHBOKiCsVYInE157k-N5HsBciyfCbsHfeG42_bFWZvEj-aA3IKI6bSSXZKYR71uYqpDY8wvqvuDT4F8H963K2WPP6Bw_5bz2DpxXTJp1yaDyHhs5ewP51FUtwCOcdkuX3-hvprfV4mmf690-CnJwgiyez-qiFyHRaCiLJMie41Vhh-yUpVWvrl3CzkxYcQTPDCr0GgrwoVR4WtYRN-TxBZimYDAsLRyN1C9p1z8TVtLCIt93Sgg-bxzig7S2NzHS-wjLWrseaHDkteFUCIZ6XziOxFchF-J0WnNTI2L58Y0BdgCtGcMUFuOLgzf_r8h72ERzx1WA0fAtPWIlK6rhtaC7vVvoYHqv75Wxx965COIHbXcPkD3j3OvE |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+novel+EyePhone%C2%A9+App+for+improving+adherence+to+glaucoma+therapy&rft.jtitle=Graefe%27s+archive+for+clinical+and+experimental+ophthalmology&rft.au=Leshno%2C+Ari&rft.au=Gaton%2C+Dan&rft.au=Singer%2C+Reut&rft.au=Eliasi%2C+Elior&rft.date=2021-05-01&rft.eissn=1435-702X&rft.volume=259&rft.issue=5&rft.spage=1253&rft_id=info:doi/10.1007%2Fs00417-021-05091-6&rft_id=info%3Apmid%2F33528649&rft.externalDocID=33528649 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0721-832X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0721-832X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0721-832X&client=summon |